Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seoul National University Hospital
The main purpose of this study is to evaluate the efficacy and safety of fixed dose rate gemcitabine and cisplatin chemotherapy followed by chemoradiation with capecitabine in patients with locally advanced pancreatic cancer.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
unresectable locally advanced pancreatic cancer
no distant metastasis
histologically confirmed adenocarcinoma of pancreas
18-75 of age
ECOG performance status 0-2
normal marrow function :
* WBC at least 3,000/mm3 OR Absolute neutrophil count at least 1,500/mm3
* Platelet count at least 100,000/mm3
normal liver function :
--Bilirubin no greater than 2.0 mg/dL AST less than 3 times upper limit of normal (ULN)
